Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
Clinical trial NCT02344407 · COMPLETED
Trial details
- NCT number
- NCT02344407
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-20
- Primary completion
- 2016-06-01
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.